Timothy Morris | CFO |
Maria Fardis | CEO |
Mark Breidenbach | Oppenheimer |
Boris Peaker | Cowen and Company |
James Birchenough | Wells Fargo Securities |
Madhu Kumar | B. Riley FBR, Inc. |
Biren Amin | Jefferies |
Good afternoon, and welcome to the Iovance Biotherapeutics Third Quarter 2018 Financial Results Conference Call. [Operator Instructions]. Please be advised that the call is being recorded at the company's request.
Now I would like to turn the conference over to Tim Morris, Chief Financial Officer at Iovance. Sir, please go ahead.